Abstract
This study investigated the aminoglycoside resistance phenotypes and genotypes, as well as the prevalence of virulence genes, in Enterococcus species isolated from clinical patients in China. A total of 160 enterococcal isolates from various clinical samples collected from September 2013 to July 2014 were identified to the species level using the VITEK-2 COMPACT system. The antimicrobial susceptibilities of the identified Enterococcus strains were determined by the Kirby-Bauer (K-B) disc diffusion method. PCR-based assays were used to detect the aminoglycoside resistance and virulence genes in all enterococcal isolates. Of 160 Enterococcus isolates, 105 were identified as E. faecium, 35 as E. faecalis, and 20 isolates were classified as "other" Enterococcus species. High-level aminoglycoside resistance (HLAR) for gentamicin, streptomycin, and both antibiotics was identified in 58.8, 50, and 34.4% of strains, respectively. The most common virulence gene (50.6% of isolates) was efaA, followed by asa1 (28.8%). The most prevalent aminoglycoside resistance genes were aac(6')-Ie-aph(2''), aph(2')-Id, aph(3')-IIIa, and ant(6')-Ia, present in 49.4%, 1.3%, 48.8% and 31.3% of strains, respectively. Overall, E. faecium and E. faecalis wer...Continue Reading
References
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·M A SchoutenJ A Hoogkamp-Korstanje
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·S J KaoJ W Chow
Mar 26, 2003·Antimicrobial Agents and Chemotherapy·Sergei B VakulenkoJoseph W Chow
May 16, 2003·Journal of Medical Microbiology·I DuprèL A Sechi
Dec 10, 2003·Journal of Medical Microbiology·Roberta CretiLucilla Baldassarri
Oct 9, 2004·Journal of Clinical Microbiology·Vanessa VankerckhovenHerman Goossens
Sep 28, 2005·The Journal of Antimicrobial Chemotherapy·Raffaele ZarrilliRiccardo Utili
Jun 15, 2007·The Journal of Antimicrobial Chemotherapy·Lourdes Garcia-MiguraLars Bogø Jensen
Aug 22, 2008·International Journal of Antimicrobial Agents·Hanna BillströmCarl Erik Nord
Nov 13, 2008·The Journal of Antimicrobial Chemotherapy·Sylvia ValdezateJuan A Saéz-Nieto
Oct 19, 2011·Journal of Food Protection·Cindy-Love TremblayMarie Archambault
Apr 12, 2012·Antimicrobial Agents and Chemotherapy·Hsih-Yeh TsaiPo-Ren Hsueh
Mar 14, 2013·International Journal of Environmental Research and Public Health·Vesna FurtulaPatricia A Chambers
Jun 19, 2013·Antimicrobial Agents and Chemotherapy·Anthony M CasapaoMichael J Rybak
Jul 24, 2013·Anaesthesiology Intensive Therapy·Aneta GuzekKrzysztof Korzeniewski
Mar 26, 2014·International Journal of Environmental Research and Public Health·Wei JiaWen Wang
Mar 29, 2014·TheScientificWorldJournal·Elango PadmasiniS Srivani Ramesh
May 7, 2014·Antimicrobial Agents and Chemotherapy·Kayoko HayakawaKeith S Kaye
May 29, 2014·Antimicrobial Agents and Chemotherapy·Usha StiefelCurtis J Donskey
Aug 26, 2014·TheScientificWorldJournal·Sara SoheiliRukman Awang Hamat
Citations
Jul 15, 2015·Molecular Medicine Reports·Chengjiang ZhouZhanli Wang
Jul 12, 2017·Journal of Medical Microbiology·Emmanuel O NgbedeAndrew M Adamu
Feb 21, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Fengjiao XuPengju Guo
Feb 28, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Basant Elmetwally AladaroseEman Salama Abdelmegeed
Jan 29, 2020·Molecular Biology Reports·Rahime Özdemir, Yasin Tuncer
Dec 2, 2018·Infectious Disorders Drug Targets·Mahmoud KhodabandehRamazan Rajabnia
Aug 29, 2019·BMC Infectious Diseases·Fakhri HaghiHabib Zeighami
Jan 17, 2019·BMC Research Notes·Yingjie TianZhanli Wang
Jan 30, 2020·Wiener medizinische Wochenschrift·Fereshteh SaffariRoya Ahmadrajabi
Mar 7, 2021·Pathogens·Shujie WangXuehui Cai